Compare RAPP & HQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | RAPP | HQH |
|---|---|---|
| Founded | 2022 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance Companies |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2024 | N/A |
| Metric | RAPP | HQH |
|---|---|---|
| Price | $29.51 | $18.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $48.50 | N/A |
| AVG Volume (30 Days) | ★ 286.4K | 155.3K |
| Earning Date | 03-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | ★ 24.34 | N/A |
| EPS | N/A | ★ 1.09 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.81 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.73 | $13.77 |
| 52 Week High | $42.27 | $20.46 |
| Indicator | RAPP | HQH |
|---|---|---|
| Relative Strength Index (RSI) | 58.37 | 48.30 |
| Support Level | $25.48 | $17.70 |
| Resistance Level | $31.57 | $19.57 |
| Average True Range (ATR) | 1.77 | 0.40 |
| MACD | 0.07 | 0.03 |
| Stochastic Oscillator | 74.09 | 67.09 |
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.